Invasive FFR — Current Applications and New Developments

1. Shaw LJ, Berman DS, Marin DJ, et al. Optimal medical therapy with or without percutaneous coronaru interventions to reduce ischaemic burden: results from the Clinical Outcomes Utilizing Revascularization and aggressive drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283-1291.10.1161/CIRCULATIONAHA.107.743963Search in Google Scholar

2. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischaemia after myocardial infarction: The SWISS II randomized controlled trial. JAMA. 2007;297:1985-1991.10.1001/jama.297.18.1985Search in Google Scholar

3. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow up of the DEFER Study. J Am Coll Cardiol. 2007;49:2105-2111.10.1016/j.jacc.2007.01.087Search in Google Scholar

4. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA. 2008;300:1765-1773.10.1001/jama.300.15.1765Search in Google Scholar

5. Melikian N, De Bondt P, Tonino P, et al. Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowing of moderate severity. Am J Cardiol. 2002;90:210-215.10.1016/S0002-9149(02)02456-6Search in Google Scholar

6. Christou MA, Siontis GC, Katristris DG, Ioannidis JP. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol. 2007;99:450-456.10.1016/j.amjcard.2006.09.09217293182Search in Google Scholar

7. Tonino PA, de Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213-224.10.1056/NEJMoa080761119144937Search in Google Scholar

8. Bourdarias JP. Coronary reserve: concept and physiological variations. Eur Heart J. 1995;16(supplI):2-6.10.1093/eurheartj/16.suppl_I.28829952Search in Google Scholar

9. Jeremias A, Whitbourn RJ, Filardo SD, et al. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J. 2000;140:651-657.10.1067/mhj.2000.10992011011341Search in Google Scholar

10. Pijls NH, Tonino PA, Fearon WF. Fractional flow reserve for guiding PCI. N Engl J Med. 2009;360:2026-2027.Search in Google Scholar

11. Vranckx P, Cutlip DE, Mc Fadden EP, Kern MJ, Mahran R, Muller O. Coronary pressure derived fractional flow reserve measurements: recommendations for standardization, recording and reporting as a core laboratory technique. Proposal for integration in clinical trials. Circ Cardiovasc Interv. 2012;5:312-317.10.1161/CIRCINTERVENTIONS.112.96851122511740Search in Google Scholar

12. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenosis in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816-2821.10.1016/j.jacc.2009.11.09620579537Search in Google Scholar

13. Lilly LS, Harvard Medical School. Pathophysiology of heart disease: a collaborative project of medical students and faculty. 5^th ed. Baltimore/MD: Wolters Kluwer Lippincott Williams & Wilkins; 2011.Search in Google Scholar

14. Leonardi RA, Townsend JC, Patel CA, et al. Left ventricular end-diastolic pressure affects measurement of fractional flow reserve. Cardiovasc Revasc Med. 2013;14:218-222.10.1016/j.carrev.2013.06.001376000623886870Search in Google Scholar

15. De Bruyne B, Piljs NH, Kalesan B, et al. Fractional flow reserve – guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2009;360:213-224.10.1056/NEJMoa080761119144937Search in Google Scholar

16. De Bruyne B, Piljs NH, Barbato E, et al. Intracoronary and intravenous adenosine 5-triphosphate, adenosine, papaverine and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877-1883.10.1161/01.CIR.0000061950.24940.8812668522Search in Google Scholar

17. Yong AS, Daniels D, De Bruyne B, et al. Fractional flow reserve assessment of left main stenosis in the presence of downstream coronary stenoses. Circ Cardiovasc Interv. 2013;6:161-165.10.1161/CIRCINTERVENTIONS.112.00010423549643Search in Google Scholar

18. Bech GJ, de Bruyne B, Piljs NH, et al. Fractional flow reserve to determine the appropiatenes of angioplasty in moderate coronary stenosis; a randomized trial. Circulation. 2001;103:2928-2934.10.1161/01.CIR.103.24.2928Search in Google Scholar

19. De Bruyne B, Piljs NH, Bartunek J, et al. Fraxctional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157-162.10.1161/01.CIR.104.2.157Search in Google Scholar

20. Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561-569.10.1253/circj.CJ-13-0161Search in Google Scholar

21. Van Belle E, Rioufol G, Pouillot C, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129:173-185.10.1161/CIRCULATIONAHA.113.00664624255062Search in Google Scholar

22. Melikian N, Cuisset T, Hamilos M, De Bruyne B. Fractional flow reserve – the influence of the collateral circulation. Int J Cardiol. 2009;132:e109-e110.10.1016/j.ijcard.2007.08.03418055036Search in Google Scholar

23. Wijns W, Kohl P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic Surgery (EACTS). Eur Heart J. 2010;31:2501-2555.10.1093/eurheartj/ehq27720802248Search in Google Scholar

24. Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side branch intervention strategy for bifurcation lesion using fractional flow reserve. Eur Heart J. 2008;29:726-732.10.1093/eurheartj/ehn04518308689Search in Google Scholar

25. Koo BK. Physiologic evaluation of bifurcation lesions using fractional flow reserve. J Interv Cardiol. 2009;22:110-113.10.1111/j.1540-8183.2009.00437.x19379467Search in Google Scholar

26. Fearon WF, Shilane D, Piljs NH, et al. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation. 2013;128:1335-1340.10.1161/CIRCULATIONAHA.113.00305923946263Search in Google Scholar

27. Ntalianis A, Sles JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274-1281.10.1016/j.jcin.2010.08.02521232721Search in Google Scholar

28. Levine GN, Bates ER, Blankenship, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ant the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-651.10.1161/CIR.0b013e31823a559622064598Search in Google Scholar

29. Fearon WF. Percutaneous Coronary Intervention Should Be Guided by Fractional Flow reserve Measurement. Circulation. 2014;129:1860-1870.10.1161/CIRCULATIONAHA.113.004300554493724799502Search in Google Scholar

30. Burzotta F, Leone AM, De Maria GL, et al. Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial. Trials. 2014;15:140.10.1186/1745-6215-15-140400135424758510Search in Google Scholar

31. Meuwissen M, Chamuleau SA, Siebes M, et al. Role of variability in microvascular resistence on fractional flow reserve and coronary blood velocity reserve in intermediate coronary lesions. Circulation. 2001;103:184-187.10.1161/01.CIR.103.2.18411208673Search in Google Scholar

32. Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012;59:1392-1402.10.1016/j.jacc.2011.11.00322154731Search in Google Scholar

33. Berry C, van t Veer M, Witt N, et al. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013;61:1421-1427.10.1016/j.jacc.2012.09.06523395076Search in Google Scholar

34. Escaned J, Echavarria-Pinto M, Garcia-Garcia HM, et al. Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADIVSE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II). JACC Cardiovasc Interv. 2015;8:824-833.10.1016/j.jcin.2015.01.02925999106Search in Google Scholar

35. Nijjer SS, Sen S, Petraco R, et al. Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery disease. JACC Cardiovasc Interv. 2014;7:1386-1396.10.1016/j.jcin.2014.06.01525459526Search in Google Scholar

36. Van Belle E. DEFINE REAL: a prospective, observational, non-randomised, European, multicentre registry, collecting real-life information for the utilisation of iFR in assessing coronary stenosis relevance in the multivessel disease patient population. Presented at: EuroPCR 2016.Search in Google Scholar

37. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235.10.1056/NEJMoa100235821247313Search in Google Scholar

38. Johnson NP, Gould KL, Di Carli MF, Taqueti VR. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future? J Am Coll Cardiol. 2016;67:2772-2788.Search in Google Scholar

39. Nijjer SS, Sen S, Petraco R, et al. Improvement in coronary haemodynamics after percutaneous coronary intervention: assessment using instantaneous wave-free ratio. Heart. 2013;99:1740-174810.1136/heartjnl-2013-304387384176224047640Search in Google Scholar

40. Fearon WF, Aarnoudse W, Pijls NH, et al. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation. 2004;109:2269-2272.10.1161/01.CIR.0000128669.99355.CB15136503Search in Google Scholar

41. De Bruyne B, Barbato E. Quantitative assessment of the coronary microvasculature: new tools for the black box. Circulation. 2013;127:2378-2379.10.1161/CIRCULATIONAHA.113.00336123681065Search in Google Scholar

42. Fearon WF, Low AF, Yong AS, et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436-2441.10.1161/CIRCULATIONAHA.112.000298542986423681066Search in Google Scholar